Synergistic inhibition by verapamil and quinine of P-glycoprotein- mediated multidrug resistance in a human myeloma cell line model

M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), SE Salmon(University of Arizona), Denise J. Roe(University of Arizona), Scott S. Emerson(Cleveland Clinic Lerner College of Medicine), WS Dalton(University of Arizona)
Blood
January 15, 1991
10.1182/blood.v77.2.348.bloodjournal772348
Cited by 85

Related Papers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
Rapid Magnetic Resonance Imaging vs Radiographs for Patients With Low Back Pain
|JAMA|2003|370
Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling
|EBioMedicine|2019|308